Quarterly ResultApr 30, 2026, 08:41 AM
RBOT Q1 Net Loss $7.3M; Going Concern Warning; NYSE Delisting
AI Summary
Vicarious Surgical Inc. reported a net loss of $7.329 million for the first quarter of 2026, a significant improvement from the $15.394 million net loss in the same period last year, primarily due to reduced operating expenses. However, the company faces substantial doubt about its ability to continue as a going concern, with current cash and investments of $3.682 million expected to fund operations only through the second quarter of 2026. The company's Class A common stock was delisted from the NYSE and now trades on the OTCQB Venture Market.
Key Highlights
- RBOT reported a net loss of $7.329M for Q1 2026, down from $15.394M in Q1 2025.
- Total operating expenses decreased to $7.502M in Q1 2026 from $15.747M in Q1 2025.
- Research and development expenses were $5.039M in Q1 2026, a decrease from $9.415M in Q1 2025.
- Cash, cash equivalents, and short-term investments totaled $3.682M as of March 31, 2026.
- The company's cash runway is expected to support operations only through Q2 2026.
- RBOT was delisted from NYSE and now quotes on OTCQB.
- Net cash used in operating activities was $6.325M in Q1 2026, compared to $11.768M in Q1 2025.
- Total stockholders' equity decreased to $3.570M as of March 31, 2026, from $9.841M at December 31, 2025.